1. Tech Startups Stoke Market For IPOs

  2. Buyout Firms Flock to Europe’s Public Markets

  3. Deal making on track for biggest year since 2011

  4. Borrowers Struggle to Raise Funds as Emerging Markets Tumble

  5. How US investment banks left European rivals in the dust

  6. U.S. Companies Begin to Chip Away at Mountain of Debt

  7. Chicago fund manager is big winner in US IPO bonanza

  8. Brushing off trade war, Chinese startups flock to US for IPOs

  9. The charts that show the extent of bankers’ summer deal drought

  10. Dealogic discusses where Go-Jek could possibly list [watch the CNBC interview]

  11. China Tower, world’s largest IPO in two years, opens flat in Hong Kong debut after raising US$6.9 billion

  12. A Tesla buyout would be the largest in history — by a wide margin

  13. BP to Buy BHP Shale Assets for More Than $10 Billion

  14. Who's Number One? Top banks in Dealogic rankings across M&A, ECM, DCM and Loans, in first half 2018

  15. Dealmaking in global payments sector hits new high

  16. IPO Market Posts Blistering First Half

  17. Upstarts Crash Wall Street’s $7 Billion Capital-Markets Party

  18. LBO Volume Surges as KKR, Others Put $1 Trillion Cash Pile to Work

  19. Hundreds of Millions in Fees at Stake in Media Merger Frenzy

  20. Why Wall Street Can Rule a Divided Europe

  21. Trade tension and rising rates hit Asian investment banking fees

  22. Twitter Plans to Sell $1 Billion in Convertible Debt

  23. Bull Market in Tech-Company Convertible Debt Rages On

  24. Companies Find Savings in Issuing Floating-Rate Bonds

  25. Soft Chinese Tech IPOs Test Next Wave of Listings

  26. Merger mania whips up $120bn of tie-ups in just one day

  27. Global IPOs slow in January-March as India overtakes China

  28. Beware the Chinese Tech IPO Rush

  29. Dim sum renaissance powered by rising renminbi

  30. Emerging market investors turn cautious on booming debt sales

  31. Quarterly Stock Market Review

  32. Cigna unveils $67bn deal to buy Express Scripts

  33. How SoftBank, World’s Biggest Tech Investor, Throws Around Its Cash

  34. Berkshire Hathaway gains $29bn on back of US tax reforms

  35. New Tax Law Haunts Companies That Did ‘Inversion’ Deals

  36. Market Turmoil Threatens IPO Recovery

  37. US IPO market has strongest start to year on record

  38. Large Deals Set Record Pace in January

  39. M&A in asset management sector climbs to 8-year high

  40. Spotify Disrupted the Music World, Now It’s Doing the Same to Wall Street

  41. Investment banking revenues rise in Europe despite M&A slump

  42. Hoping for an Avalanche of Huge IPOs in 2018? Get Ready to Keep Waiting

  43. China Drives Asia's Record International Bond Issuances For 2017 - Dealogic

  44. London’s main and junior stock exchanges hosted floats valued at nearly $14 billion

  45. Global number of IPOs highest since financial crisis

  46. Companies shunned all-stock mergers in 2017

  47. Hong Kong risks losing listings crown to New York

  48. Takeovers Roar to Life as Companies Hear Footsteps From Tech Giants

  49. Riskiest countries are selling debt at record rate

  50. IPOs Roar Back World-Wide, With Asia Driving the Boom

  51. Break Up And Die: Why Spinoff Fever Can’t Last Forever

  52. Apple taps debt markets to fund $300bn in returns

  53. In the wake of Broadcom-Qualcomm, here are the largest tech deals ever

  54. M&A国際化助言は外資優勢

  55. Wall Street banks rake in bumper fees from leveraged loans

  56. Chinese companies still doing plenty of outbound deals

  57. Here's what driving listings in the US

  58. Empowering staff to create a pioneering workplace culture

  59. US company debt sales power ahead as borrowing costs drop

  60. Nasdaq Looks to Ease Rules for Blank-Check IPOs

  61. Snap, Blue Apron Shake Confidence in Startup Valuations

  62. U.S. Government Bonds Pull Back as AT&T Prints Year’s Largest Corporate-Bond Deal

  63. The end of Abenomics will test Japan's appetite for M&A

  64. Occupier Insights: 20 minutes with Dealogic

  65. It’s Alive! Sterling Bond Market Bounces Back

  66. Boutique advisers crash M&A league table thanks to high fees

  67. Corporate America’s rush for cheap money in Europe is devastating for investors there

  68. Foreign predators scent a bargain

  69. Chinese, Western Banks’ Battle for Dominance Reaches Bond Market

  70. In the shadow of Aramco, the Middle East’s IPO market picks up

  71. Asia’s Appetite Sends Junk Bonds Jumping

  72. Record Bond Issuance Shows Many Investors Still Doubt Economic Growth

  73. China comes roaring back in the global IPO market

  74. Upbeat mood drives record emerging market sovereign debt sales

  75. London's share of global IPOs lowest since 2012

  76. Chinese firms slow their overseas buying spree

  77. First Snap, Now Canada Goose: Warning Signs for Trendy IPOs

  78. Junk bonds’ stellar run under threat from a hawkish Fed

  79. Why Asia lacks dramatic takeover battles

  80. Success of European block trades bodes well for IPO outlook

  81. Flurry of IPOs Poised to Test Market for New Offerings

  82. China outperforms in a dismal global IPO market

  83. Merger & Acquisition Deal Volume

  84. Wall Street debt issuance off to a record start in 2017

  85. The Bests and the Bloopers from the Year in Deals

  86. Hong Kong and New York battle for IPO dominance

  87. Japan Inc on the hunt for post-Brexit deals

  88. Record year for China’s outbound M&A as it overtakes US for the first time

  89. Banks Fight for Block Trades Amid Stalled IPO Market

  90. AT&T’s Deal for Time Warner Faces Tough Climate

  91. Global corporate bond sales slow ahead of US election

  92. Global debt sales eclipse $5tn in ’16

  93. Wall Street’s IPO Business: The Worst in 20 Years

  94. Global bond issuance highest in nearly a decade

  95. Issuance of Dollar Bonds Surges in Asia

  96. Anemic IPO Market Is Poised for a Rebound

  97. Boutiques catch up with global firms in M&A

  98. New Tool for Central Banks: Buying Corporate Bonds

  99. Tech dealmakers are partying like it's 2000

  100. Buyside Signs Up For IPO Automation

  101. SoftBank to acquire UK’s Arm Holdings for £24.3bn

  102. Line Soars After Debut, Amid Hunger for Tech Listings

  103. Boutique banking: Upstarts are out to take a big bite out of Wall Street

  104. Australian investment banking revenue lowest since 2010, Dealogic says

  105. Brexit keeps European IPO market on hold

  106. Has there been a backlog of IPO deals post-Brexit?

  107. The Brexit Bounce That Won’t Carry Investment Banks Far

  108. Brexit Vote Could Curb Asian Buyers’ Appetite for U.K. Assets

  109. Brexit could put Chinese buying of UK assets on hold

  110. Hong Kong’s Likely Return as Top IPO Market Not All Rosy

  111. Technology Busiest Sector in Merger Deals This Year

  112. IPO activity showing a recovery in Q2

  113. LinkedIn Co-Founder Reid Hoffman Calls Microsoft Deal a ‘Re-Founding Moment’

  114. Chinese Companies: The New Uninvited Guests in M&A

  115. China push in international bonds to support weakening renminbi

  116. Time running out for US IPO market to find some gas

  117. European issuers welcome new Asian liquidity

  118. Few Spinoffs Make a Clean Break

  119. Philips Lighting leaps 10% on market debut

  120. Markets are gearing up for the ECB's corporate debt spree

  121. Outbound M&As expected to continue leading global market

  122. Bayer launches $62bn cash bid for Monsanto

  123. Midea’s Robot Raid Continues China’s M&A Frenzy in Germany

  124. China securities houses on track for record bond fees

  125. Will IPOs Pick Up? June Will Tell

  126. Europe’s corporate bond market hums ahead of ECB

  127. Break Fee Bonanza as Deals Fail

  128. Oil Bust Gives Billionaire Deal-Maker Buyer’s Remorse

  129. Chinese Acquisitions of Foreign Firms Already at Full-Year Record

  130. Korea's mid-sized builders up for sale

  131. 2016 Is Already a Record Year for Failed U.S. Deals

  132. China overtakes US as top nation for technology acquisitions

  133. China investment in the US hits record $15bn

  134. Pfizer, Allergan deal dead, what could be next?

  135. Pfizer-Allergan Deal Sets Another Record With Its Demise